RESUMEN
In 2019, an outbreak of Spodoptera frugiperda (Smith) was first reported in Korea. This study aimed to determine the growth rate and feeding amount of S. frugiperda by temperature to establish the right time window for its control and management. Linear regression analysis was used to determine the growth period and thermal requirements of S. frugiperda. The longest growth period of 97.2 ± 1.2 days was observed at 16 °C, and the shortest growth period of 15.5 ± 0.7 days was observed at 36 °C. In terms of each growth stage, the pupal period was the longest at all temperatures, followed by the egg period. The maximum corn leaf feeding amount (6.61 g) was observed for the larvae grown at 16 °C, and the minimum (2.9 g) was observed at 36 °C. However, the daily feeding amount of S. frugiperda larvae was the highest at 28 °C and 32 °C. The hatching rate according to temperature exceeded 70% at 24 °C, 28 °C, and 32 °C, and the survival rate of larvae and pupae was 100% at 24 °C to 32 °C. Based on these results, a temperature range of 28 °C to 32 °C is proposed as the optimum temperature for the growth of S. frugiperda.
RESUMEN
Transcatheter aortic valve replacement (TAVR) is an effective treatment option for patients with severe symptomatic aortic stenosis. Nonetheless, there is a paucity of data regarding the differences in the clinical outcomes of TAVR procedures between elderly and super-elderly patients. This study aimed to compare the clinical characteristics and outcomes of patients aged 65 to 79 years and ≥80 years who underwent TAVR for aortic stenosis. The clinical characteristics and outcomes of 134 patients with aortic stenosis who underwent TAVR were analyzed. Patients were categorized into 2 groups: an elderly group (EG; 65-79 years) and a super-elderly group (SEG) (≥80 years). The in-hospital and follow-up clinical outcomes were compared between the 2 groups. The EG tended to be more overweight, obese, and diabetic than the SEG, whereas the SEG had a higher surgical risk but lower creatinine clearance, hematocrit level, and effective orifice area than the EG. However, no difference was found in in-hospital clinical outcomes between the 2 groups, except for atrial fibrillation. In the propensity score matching and inverse probability of treatment weighting-adjusted analyses, these results were similar. All follow-up clinical outcomes were similar, except for rehospitalization, which was statistically attenuated after propensity score matching and inverse probability of treatment weighting-adjusted analyses. TAVR was associated with similar safety outcomes in the EG (65-79 years) and the SEG (≥80 years). Advanced age is not negatively associated with clinical outcomes after the TAVR procedure.
